News Sentiment

MDWD sentiment intelligence

Mediwound Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 14.29 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-5.7% over one week, +0.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -5.7% Price reacting lower
Trend fit Trend inactive 0.5% over four weeks
Fair value -10.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 40
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
TradingKey 8
Quiver Quantitative 5
Stock Traders Daily 3
Stock Titan 3
simplywall.st 3
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 26
Analyst action 4
Balance sheet 2
Guidance 2
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
Stock Traders Daily Direct company coverage

(MDWD) Volatility Zones as Tactical Triggers

This article provides an AI-generated analysis of Mediwound Ltd. (NASDAQ: MDWD), highlighting a mixed sentiment and choppy conditions across different time horizons. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with spec

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 18:10
Source
Stock Traders Daily
TradingView Direct company coverage

Enterprise value to EBITDA forward of MediWound Ltd. – NASDAQ:MDWD

This page provides financial information for MediWound Ltd. (NASDAQ: MDWD), specifically focusing on its enterprise value to EBITDA forward metric. It appears to be a financial data presentation page from TradingView, offering an overview of the company's financial performance.

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 16:41
Source
TradingView
Finviz Direct company coverage

MDWD - MediWound Ltd Volatility & Greeks

This article provides a comprehensive financial overview of MediWound Ltd (MDWD), detailing its volatility, key financial metrics, stock performance, and various ratios. It covers aspects from market capitalization and income to insider ownership, analyst recommendations, and his

Tone
Neutral 50/100
Event
Analyst action
Published
03 Jul 2026 08:41
Source
Finviz
TradingView Direct company coverage

Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W

This article displays the "Enterprise value to revenue forward" metric for MediWound Ltd. (FWB: M8W) on the TradingView platform. The content primarily focuses on the financial data point for the company. It indicates that the market for MediWound Ltd. is currently closed with no

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 00:40
Source
TradingView
www.marketscreener.com Direct company coverage

MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index

MediWound Ltd. (NasdaqGM: MDWD), a biopharmaceutical company specializing in tissue repair and regeneration, has been added to the Russell 2000 Growth-Defensive Index. The company's portfolio includes NexoBrid for burn care and other therapeutic candidates, and it has an average

Tone
Positive 70/100
Event
Market update
Published
28 Jun 2026 21:56
Source
www.marketscreener.com
Stock Traders Daily Direct company coverage

Price-Driven Insight from (MDWD) for Rule-Based Strategy

The article provides a price-driven analysis for Mediwound Ltd. (NASDAQ: MDWD) using AI models, highlighting a potential short setup with an exceptional risk-reward ratio. It details three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—alon

Tone
Negative 38/100
Event
Market update
Published
27 Jun 2026 16:38
Source
Stock Traders Daily
TradingView Direct company coverage

Price to book forward of MediWound Ltd. – SWB:M8W

This article focuses on the "Price to book forward" financial metric for MediWound Ltd., traded on the Stuttgart Stock Exchange under the symbol M8W. The content is primarily a page title within a financial data platform, indicating a specific financial view for the company. No a

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 02:09
Source
TradingView
TradingView Direct company coverage

MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD)

This article provides key financial data and analyst estimates for MediWound Ltd. (NASDAQ: MDWD), including its current stock price, historical highs and lows, market capitalization, and upcoming earnings report. It also includes general financial statements such as revenue, net

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 01:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of MediWound Ltd. – SWB:M8W

The article focuses on the "Enterprise value to revenue forward" financial metric for MediWound Ltd. (SWB:M8W), a pharmaceutical company listed on the Stuttgart Stock Exchange. It appears to be a financial snapshot or a data point provided by TradingView, indicating specific peri

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 21:12
Source
TradingView
TradingView Direct company coverage

Price to sales forward of MediWound Ltd. – NASDAQ:MDWD

This article provides the "Price to sales forward" metric for MediWound Ltd. (NASDAQ: MDWD). It is a financial data point presented within the TradingView platform, specifically under the company's financial overview. The article itself is a data presentation rather than an analy

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 19:12
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of MediWound Ltd. – SWB:M8W

This article focuses on the "Price to earnings forward" metric for MediWound Ltd. (SWB:M8W) as listed on the Stuttgart Stock Exchange. The content provided is minimal, showing only the section heading and placeholders for "Period," "Value," "Change," and "Change %," indicating no

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 00:40
Source
TradingView
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Mediwound Ltd (MDWD), detailing its current price momentum, support and resistance levels, and the readings from various technical indicators and moving averages. The analysis suggests the stock is currently suitable for range-bound s

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 00:12
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis

Mediwound Ltd (MDWD) currently holds a valuation score of 7.98, ranking it 116 out of 157 in the Pharmaceuticals industry. The company's P/E ratio is reported at -6.65, which is notably below its recent high and above its recent low. However, relevant data for P/B, P/S, and P/CF

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 10:14
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Institutional Confidence

The article analyzes the institutional confidence in Mediwound Ltd (MDWD), noting its current score of 5.00, ranking 73rd in the Pharmaceuticals industry. Institutional shareholding has increased to 57.77%, with Steven Cohen being the largest shareholder. The article also lists o

Tone
Positive 67/100
Event
Market update
Published
22 Jun 2026 11:40
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Mediwound Ltd (MDWD)'s dividend history and stock split events. It indicates that the company has not distributed any dividends over the past five years. The record shows a 7-to-1 merger stock split that occurred on December 19, 2022.

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 21:40
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Mediwound Ltd (MDWD), noting its stable financial status but low operating efficiency, ranking 138 out of 157 in the Pharmaceuticals industry with a score of 6.66. The company experienced a 62.71% year-over-year decrease in qua

Tone
Negative 30/100
Event
Market update
Published
18 Jun 2026 09:10
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a breakdown of Mediwound Ltd's (MDWD) revenue by region. As of April 6th, the company's revenue is primarily from the USA (69.49%), with the remaining 30.51% from the EU and other international markets. The data for business segments and profit contribution

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 06:10
Source
TradingKey
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Mediwound Ltd (MDWD), listing major shareholders and their respective proportions, along with a breakdown by shareholder type. It also provides institutional shareholding trends over several quarters, including changes in the numb

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:10
Source
TradingKey
Simply Wall Street Direct company coverage

MediWound (Nasdaq:MDWD) - Stock Analysis

MediWound Ltd. (Nasdaq: MDWD) is a biopharmaceutical company specializing in non-surgical solutions for tissue repair and regeneration. The article provides a detailed stock analysis, highlighting its US$183.0m market cap and a current share price of US$14.24, with analysts sugge

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 22:10
Source
Simply Wall Street
TradingKey Direct company coverage

Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Mediwound Ltd (MDWD), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 6 analysts, the stock has an average target price of $32.00, with a consensus of a "Buy" trend. The article also

Tone
Positive 74/100
Event
Earnings
Published
17 Jun 2026 21:10
Source
TradingKey
Moomoo Direct company coverage

MediWound Slips After 1Q Loss Widens

MediWound reported a wider first-quarter loss, with EPS of -$0.36 compared to -$0.28 a year ago, missing analyst expectations. Revenue also declined by 4.3% to $4.7 million, missing forecasts. The company reaffirmed its full-year 2026 revenue guidance.

Tone
Negative 28/100
Event
Earnings
Published
13 Jun 2026 07:10
Source
Moomoo
MarketBeat Direct company coverage

Maxim Group Issues Negative Estimate for MediWound Earnings

Maxim Group has issued a negative estimate for MediWound (NASDAQ:MDWD) earnings, lowering its Q2 2026 EPS forecast to ($0.72) from ($0.58) and reducing estimates for several subsequent periods. This revision comes despite MediWound recently beating EPS expectations in its latest

Tone
Negative 36/100
Event
Earnings
Published
06 Jun 2026 06:40
Source
MarketBeat
Stock Traders Daily Direct company coverage

(MDWD) as a Liquidity Pulse for Institutional Tactics

The article analyzes Mediwound Ltd. (NASDAQ: MDWD) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It provides specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with mu

Tone
Negative 30/100
Event
Balance sheet
Published
05 Jun 2026 13:56
Source
Stock Traders Daily
GuruFocus Direct company coverage

Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD)

Nachum Shamir, a Director at MediWound Ltd (MDWD), recently purchased 6,000 shares of the company, bringing his total ownership to 1,200 shares. This transaction follows a trend of three insider buys and no sells over the past year, indicating positive insider sentiment. Despite

Tone
Positive 70/100
Event
Market update
Published
05 Jun 2026 01:39
Source
GuruFocus